BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36480885)

  • 1. [Full-field stimulus threshold testing for evaluation of the retinal function in patients with inherited retinal dystrophy].
    Li H; Zou X; Han XX; Sui RF
    Zhonghua Yan Ke Za Zhi; 2022 Dec; 58(12):1039-1044. PubMed ID: 36480885
    [No Abstract]   [Full Text] [Related]  

  • 2. Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation-Associated Inherited Retinal Degeneration in a Clinical Setting.
    Lorenz B; Künzel SH; Preising MN; Scholz JP; Chang P; Holz FG; Herrmann P
    Ophthalmology; 2024 Feb; 131(2):161-178. PubMed ID: 37704110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline.
    Birch DG; Cheng P; Duncan JL; Ayala AR; Maguire MG; Audo I; Cheetham JK; Durham TA; Fahim AT; Ferris FL; Heon E; Huckfeldt RM; Iannaccone A; Khan NW; Lad EM; Michaelides M; Pennesi ME; Stingl K; Vincent A; Weng CY;
    Transl Vis Sci Technol; 2020 Oct; 9(11):9. PubMed ID: 33133772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychophysically determined full-field stimulus thresholds (FST) in retinitis pigmentosa: relationships with electroretinography and visual field outcomes.
    Messias K; Jägle H; Saran R; Ruppert AD; Siqueira R; Jorge R; Messias A
    Doc Ophthalmol; 2013 Oct; 127(2):123-9. PubMed ID: 23733195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-month Natural History Study of Centrosomal Protein 290 (CEP290)-associated Inherited Retinal Degeneration.
    Pierce EA; Ashimatey BS; Jayasundera T; Hoyng C; Lam BL; Lorenz B; Kim K; Rashid A; Myers R; Pennesi ME
    Ophthalmol Sci; 2024; 4(5):100483. PubMed ID: 38881603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatic Full-Field Stimulus Threshold and Pupillography as Functional Markers for Late-Stage, Early-Onset Retinitis Pigmentosa Caused by
    Stingl KT; Kuehlewein L; Weisschuh N; Biskup S; Cremers FPM; Khan MI; Kelbsch C; Peters T; Ueffing M; Wilhelm B; Zrenner E; Stingl K
    Transl Vis Sci Technol; 2019 Nov; 8(6):45. PubMed ID: 31879567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining inclusion criteria and endpoints for clinical trials: a prospective cross-sectional study in CRB1-associated retinal dystrophies.
    Talib M; van Schooneveld MJ; Wijnholds J; van Genderen MM; Schalij-Delfos NE; Talsma HE; Florijn RJ; Ten Brink JB; Cremers FPM; Thiadens AAHJ; van den Born LI; Hoyng CB; Meester-Smoor MA; Bergen AA; Boon CJF
    Acta Ophthalmol; 2021 May; 99(3):e402-e414. PubMed ID: 33528094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective Outcomes to Evaluate Voretigene Neparvovec Treatment Effects in Clinical Practice.
    Melillo P; Testa F; Di Iorio V; Karali M; Citro A; Della Corte M; Rossi S; Banfi S; Simonelli F
    Ophthalmol Retina; 2024 Jul; 8(7):688-698. PubMed ID: 38295874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between residual visual field and full-field stimulus testing in patients with late-stage retinal degenerative diseases.
    Sakai D; Maeda T; Yamamoto M; Yokota S; Maeda A; Hirami Y; Nakamura M; Kurimoto Y; Mandai M
    Sci Rep; 2024 Feb; 14(1):2793. PubMed ID: 38307956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of Full-Field Stimulus Threshold With Functional and Anatomical Outcome Measurements in Advanced Retinitis Pigmentosa.
    Ngo WK; Jenny LA; Kim AH; Kolesnikova M; Greenstein VC; Tsang SH
    Am J Ophthalmol; 2023 Jan; 245():155-163. PubMed ID: 35870488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-field Scotopic Threshold Improvement after Voretigene Neparvovec-rzyl Treatment Correlates with Chorioretinal Atrophy.
    Stingl K; Stingl K; Schwartz H; Reid MW; Kempf M; Dimopoulos S; Kortuem F; Borchert MS; Lee TC; Nagiel A
    Ophthalmology; 2023 Jul; 130(7):764-770. PubMed ID: 36822437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic
    Kiraly P; Cottriall CL; Taylor LJ; Jolly JK; Cehajic-Kapetanovic J; Yusuf IH; Martinez-Fernandez de la Camara C; Shanks M; Downes SM; MacLaren RE; Fischer MD
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between broadband and monochromatic photopic negative response in full-field electroretinogram in controls and subjects with primary open-angle glaucoma.
    Banerjee A; Khurana M; Sachidanandam R; Sen P
    Doc Ophthalmol; 2019 Feb; 138(1):21-33. PubMed ID: 30635745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE NATURAL HISTORY OF FULL-FIELD STIMULUS THRESHOLD DECLINE IN CHOROIDEREMIA.
    Dimopoulos IS; Freund PR; Knowles JA; MacDonald IM
    Retina; 2018 Sep; 38(9):1731-1742. PubMed ID: 28800019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials.
    Maguire AM; Russell S; Wellman JA; Chung DC; Yu ZF; Tillman A; Wittes J; Pappas J; Elci O; Marshall KA; McCague S; Reichert H; Davis M; Simonelli F; Leroy BP; Wright JF; High KA; Bennett J
    Ophthalmology; 2019 Sep; 126(9):1273-1285. PubMed ID: 31443789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voretigene Neparvovec Gene Therapy in Clinical Practice: Treatment of the First Two Italian Pediatric Patients.
    Testa F; Melillo P; Della Corte M; Di Iorio V; Brunetti-Pierri R; Citro A; Ferrara M; Karali M; Annibale R; Banfi S; Rossi S; Simonelli F
    Transl Vis Sci Technol; 2021 Aug; 10(10):11. PubMed ID: 34554209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early light deprivation effects on human cone-driven retinal function.
    Esposito Veneruso P; Ziccardi L; Magli G; Parisi V; Falsini B; Magli A
    Acta Ophthalmol; 2017 Mar; 95(2):133-139. PubMed ID: 27535202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRB1-Associated Retinal Dystrophies: A Prospective Natural History Study in Anticipation of Future Clinical Trials.
    Nguyen XT; Talib M; van Schooneveld MJ; Wijnholds J; van Genderen MM; Schalij-Delfos NE; Klaver CCW; Talsma HE; Fiocco M; Florijn RJ; Ten Brink JB; Cremers FPM; Meester-Smoor MA; van den Born LI; Hoyng CB; Thiadens AAHJ; Bergen AA; Boon CJF
    Am J Ophthalmol; 2022 Feb; 234():37-48. PubMed ID: 34320374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.
    Roman AJ; Schwartz SB; Aleman TS; Cideciyan AV; Chico JD; Windsor EA; Gardner LM; Ying GS; Smilko EE; Maguire MG; Jacobson SG
    Exp Eye Res; 2005 Feb; 80(2):259-72. PubMed ID: 15670804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multimodal Approaches for the Analysis of Retinal Functional Disorders―Focusing on Retinal Detachment].
    Terasaki H
    Nippon Ganka Gakkai Zasshi; 2017 Mar; 121(3):185-231. PubMed ID: 30088405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.